INOSITOLPHOSPHOGLYCAN AND RIBOSE FOR TREATMENT OF ISCHAEMIA-REPERFUSION INJURY

摘要

Compositions comprising inositolphosphoglycans (IPGs) and ribose are disclosed, and their use in the prevention or treatment of ischaemic-reperfusion injury. This treatment increases the energy generating systems of cells by employing the mitochondrial oxidative restoration system. The use of the compositions in preserving organs for transplantation is also disclosed.